Cargando…

Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension

A significant glycolytic shift in the cells of the pulmonary vasculature and right ventricle during pulmonary arterial hypertension (PAH) has been recently described. Due to the late complications and devastating course of any variant of this disease, there is a great need for animal models that rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izquierdo-Garcia, Jose L., Arias, Teresa, Rojas, Yeny, Garcia-Ruiz, Victoria, Santos, Arnoldo, Martin-Puig, Silvia, Ruiz-Cabello, Jesus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104186/ https://www.ncbi.nlm.nih.gov/pubmed/30159317 http://dx.doi.org/10.3389/fcvm.2018.00110

Ejemplares similares

Metabolic reprogramming: A novel metabolic model for pulmonary hypertension
por: Liu, Xuhan, et al.
Publicado: (2022)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension
por: Liu, Jixiang, et al.
Publicado: (2022)

Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty
por: Lechuga-Vieco, Ana Victoria, et al.
Publicado: (2022)

Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023)

New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans
por: Bujak, Renata, et al.
Publicado: (2016)

The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
por: Xu, Yu, et al.
Publicado: (2023)

Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart
por: Killeen, M J, et al.
Publicado: (2007)

Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension
por: Hur, David J., et al.
Publicado: (2019)

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
por: Maeder, Micha T., et al.
Publicado: (2021)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure
por: Banerjee, Somanshu, et al.
Publicado: (2022)

Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart
por: Killeen, M J, et al.
Publicado: (2008)

Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
por: Hamberger, Florian, et al.
Publicado: (2022)

MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
por: Carregal-Romero, Susana, et al.
Publicado: (2020)

Calmodulin kinase II initiates arrhythmogenicity during metabolic acidification in murine hearts
por: Pedersen, T H, et al.
Publicado: (2009)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review
por: Dzudie, Anastase, et al.
Publicado: (2014)

Assessment of regional pulmonary blood flow using (68)Ga-DOTA PET
por: Velasco, Carlos, et al.
Publicado: (2017)

Right Heart Chambers Longitudinal Strain Provides Enhanced Diagnosis and Categorization in Patients With Pulmonary Hypertension
por: Espinola-Zavaleta, Nilda, et al.
Publicado: (2022)

The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases
por: Tadic, Marijana, et al.
Publicado: (2021)

Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2023)

Reduction of Pulmonary Hypertension After Transition to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction
por: Burgdorf, Christof, et al.
Publicado: (2021)

Exercise Systolic Reserve and Exercise Pulmonary Hypertension Improve Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Verwerft, Jan, et al.
Publicado: (2022)

An unexpected cause of pulmonary hypertension
por: Cao, Yunshan, et al.
Publicado: (2020)

Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Zhang, Yi, et al.
Publicado: (2022)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart
por: van der Pol, A., et al.
Publicado: (2020)

Haemodynamic and structural correlates of the first and second heart sounds in pulmonary arterial hypertension: an acoustic cardiography cohort study
por: Chan, William, et al.
Publicado: (2013)

Animal models of pulmonary hypertension due to left heart disease
por: Liu, Shao‐Fei, et al.
Publicado: (2022)

Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension
por: Rieth, Andreas J., et al.
Publicado: (2022)

Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts
por: Goddard, C A, et al.
Publicado: (2008)

Transverse cardiac slicing and optical imaging for analysis of transmural gradients in membrane potential and Ca(2+) transients in murine heart
por: Wen, Q., et al.
Publicado: (2018)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores
por: Zhang, Y, et al.
Publicado: (2010)

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy
por: Ruiz, George, et al.
Publicado: (2018)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vosd7ra7dgihg9hehgirapehjn